TriangleNCT04101331 · OUTCOME
Number of Subjects With Treatment Related Adverse Event
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- From the date of first treatment until the date of the last treatment + 37 days, up to 199 weeks.
What was measured
Number of subjects who had treatment (AFM13) related Adverse Events.
Analysis population: The safety set consisted of all subjects who received at least one dose of AFM13 and had at least one post-baseline safety assessment.
Groups in this outcome
Cohort A
Subjects with Relapsed or Refractory CD30 positive Peripheral T-cell Lymphoma (PTCL).
| Group | Source count |
|---|---|
| Cohort A | 108 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Cohort A | 105 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 105
- denoms
- counts
- group Id
- OG000
- value
- 108
- units
- Participants
- description
- Number of subjects who had treatment (AFM13) related Adverse Events.
- groups
- description
- Subjects with Relapsed or Refractory CD30 positive Peripheral T-cell Lymphoma (PTCL).
- id
- OG000
- title
- Cohort A
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- The safety set consisted of all subjects who received at least one dose of AFM13 and had at least one post-baseline safety assessment.
- reporting Status
- POSTED
- time Frame
- From the date of first treatment until the date of the last treatment + 37 days, up to 199 weeks.
- title
- Number of Subjects With Treatment Related Adverse Event
- type
- SECONDARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice